文献速递牙体牙髓病

症状性牙髓炎客观评估的分子生物标志物:系统综述与Meta分析

Molecular biomarkers for objective assessment of symptomatic pulpitis: A systematic review and meta-analysis.
PubMed 文献 · Int Endod J · 2023-07-17

低质量证据显示IL-8与IL-6在区分健康牙髓与提示不可复性牙髓炎的自发性疼痛牙髓方面具有一定诊断准确性,但尚无标志物能高诊断比值比区分不同牙髓炎状态。

要点

  • IL-8和IL-6区分健康牙髓与自发性疼痛牙髓有一定诊断准确性,但证据质量低
  • 尚无生物标志物能以高诊断比值比区分不同牙髓炎状态,证据质量极低
  • 有限数据提示高水平基质金属蛋白酶9与全冠髓切断术较差预后相关

核心结论

  • 低质量证据提示IL-8和IL-6在区分健康牙髓与表现自发性疼痛的牙髓方面显示一定诊断准确性。
  • 尚无标志物显示高诊断比值比及区分不同牙髓炎状态的能力,证据质量极低。
  • 需开展标准化生物标志物诊断与预后研究,聚焦能准确判定牙髓炎症程度的方法。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed/MEDLINE、Ovid SP、Cochrane CENTRAL、ICTRP、ClinicalTrials.gov、Embase、Web of Science和Scopus,检索时间为2023年5月。
  • 纳入前瞻性与回顾性观察研究及随机试验,对象为具有明确牙髓诊断的活髓恒牙人类受试者,排除乳牙、体外与动物研究。
  • 偏倚风险采用改良Downs and Black质量评估清单,Meta分析采用Meta-DiSc 2.0和RevMan的双变量随机效应模型,证据质量采用GRADE评估。
  • 注册号PROSPERO CRD42021259305。

主要发现

  • 多数纳入研究质量为低和一般。
  • IL-8和IL-6在区分健康牙髓与表现自发性疼痛(提示不可复性牙髓炎)的牙髓方面显示较高敏感性、特异性和诊断比值比(低质量证据)。
  • 没有任何生物标志物显示高诊断比值比及区分不同牙髓炎状态的能力(极低质量证据)。
  • 有限数据提示高水平基质金属蛋白酶9与全冠髓切断术较差预后相关。

关键数值与推荐

  • IL-8和IL-6区分健康牙髓与自发性疼痛牙髓的诊断准确性获低质量证据支持。
  • 区分不同牙髓炎状态的生物标志物证据质量为极低。
  • 基质金属蛋白酶9与全冠髓切断术预后的关联仅有有限数据支持。

临床怎么用

  • IL-8和IL-6有望作为辅助判断牙髓状态、识别自发性疼痛牙髓的候选标志物,但证据质量低,尚不足以单独用于临床决策。
  • 目前尚无可靠标志物区分不同牙髓炎状态,临床牙髓诊断仍应结合症状与常规检查。
  • 关注基质金属蛋白酶9等标志物对活髓治疗预后预测的潜在价值,有待更高质量研究验证。

局限性

  • 多数纳入研究质量为低和一般,整体证据质量低至极低。
  • 已识别的分子炎症标志物无法区分自发性疼痛与非自发性疼痛牙髓。
  • 需改进研究质量并探索与愈合和修复相关的其他分子。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory biomarkers are potentially useful targets for pulpal diagnostic tests that can identify pulp status and predict vital pulp treatment (VPT) outcome, however, their accuracy is unknown. OBJECTIVES: (1) Calculate sensitivity, specificity and diagnostic odds ratio (DOR) of previously investigated pulpitic biomarkers; (2) Determine if biomarker levels discriminate between clinical diagnoses of pulpitis based on the presence or absence of spontaneous pain (3) Evaluate if biomarker level can predict VPT outcome. METHODS: Searches: PubMed/MEDLINE, Ovid SP, Cochrane Central Register of Controlled Trials (CENTRAL), International Clinical Trials Registry Platform (ICTRP), ClinicalTrials.gov, Embase, Web of Science and Scopus in May 2023. INCLUSION: prospective and retrospective observational studies and randomized trials. Participants were humans with vital permanent teeth and a well-defined pulpal diagnosis. EXCLUSION: deciduous teeth, in vitro and animal studies. Risk of bias was assessed with modified-Downs and Black quality assessment checklist. Meta-analysis was performed using bivariate random effect model in Meta-DiSc 2.0 and RevMan and the quality of the evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation. RESULTS: Fifty-six studies were selected, reporting >70 individual biomolecules investigating pulpal health and disease at the gene and protein level. Most studies were of low and fair quality. Among the biomolecules investigated, IL-8 and IL-6 demonstrated a level of diagnostic accuracy with high sensitivity, specificity and DOR to discriminate between healthy pulps and those exhibiting spontaneous pain suggestive of IRP (low-certainty evidence). However, none was shown to have high DOR and the ability to discriminate between pulpitic states (very low certainty evidence). Limited data suggests high levels of matrix metalloproteinase 9 correlate with poorer outcomes of full pulpotomy. DISCUSSION: The inability of identified molecular inflammatory markers to discriminate between dental pulps with spontaneous and non-spontaneous pain should shift the focus to improved study quality or the pursuit of other molecules potentially associated with healing and repair. CONCLUSIONS: Low-quality evidence suggests IL-8 and IL-6 demonstrated level of diagnostic accuracy to discriminate between healthy pulps and those exhibiting spontaneous pain. There is a need for standardized biomarker diagnostic and prognostic studies focusing on solutions that can accurately determine the degree of pulp inflammation. REGISTRATION: PROSPERO CRD42021259305.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Karrar RN, Cushley S, Duncan HF, et al. Molecular biomarkers for objective assessment of symptomatic pulpitis: A systematic review and meta-analysis. Int Endod J. 2023. PMID: 37392154. doi:10.1111/iej.13950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。